Author, date and country | Patient group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
Gibson 2005 UK | 38 toes undergoing arthrodesis (mean age 54.2 ± 10.6yrs) compared to 39 toes undergoing a Biomet unconstrained total arthroplasty (55.5 ± 8.7yrs) for osteoarthritis (Hallux Rigidus) of the 1st MTPJ. | Level I, prospective randomized study. | VAS for pain (arthrodesis v arthroplasty) | @ 1 yr FU 14±21 v 34±28, 2 yrs FU 34±28 . Effect size 0.80 (95% CI, 0.31 – 1.28) | Surgeons and subjects not blinded to group allocation. Small deviations from protocol. Some patients had bilateral procedures which may have affected pain perception, |
Maximal 1st MTPJ Plantar pressure (within groups analysis compared to baseline) | @ 2 yrs FU arthroplasty group reduced by 2.3 N/cm2 (NSS). Arthrodesis group increased by 2.9N/cm2 (NSS) | ||||
Park 2019 Korea | 7 studies; 740 subjects. Mix of retrospective & prospective studies comparing arthrodesis and arthroplasty of the first MTP joint for the treatment of advanced hallux rigidus. | Systematic review and meta-analysis | 1. VAS for pain | 1. Decrease in VAS from arthrodesis. Overall Mean Diff arthrodesis versus arthroplasty = 9.81; (95% CI: 6.54 , 13.09) p < .00001 | Varied type of implants used for arthroplasty. |
2. AOFAS-HMI | 2. NSS | ||||
3. re-operation rate | 3. NSS | ||||
4. complication rate | 4. NSS | ||||
Stevens 2017 Netherlands | 741 feet in 678 patients mean ages range 50 - 68.5 yrs Mix of retropective & prospective studies of arthrodesis and arthroplasty of the first MTP joint for the treatment of symptomatic end stage hallux rigidus. 1 RCT s, 7 retrospective cohort studies, 3 retrospective & 2 prospective case series | Systematic review without meta-analysis | 1. AOFAS_HMI score | 1. Arthrodesis group had significantly lower (better) AOFAS-HMI scores than arthroplasty group (p < 0.0001) | No meta analysis Effects of arthrodesis and arthroplasty analysed separately between studies but not within studies. |
2. VAS pain | 2. Arthrodesis group had significantly lower VAS pain score than arthroplasty group (p < 0.0001) | ||||
Brewster 2010 UK | 10 articles, 5 on arthroplasty. 5 on arthrodesis 5 retrospective case series 5 prospective case series 242 patients surgery to first MTPJ. Pathology not specified | Systematic review without meta-analysis | 1. AOFAS-HMI | 1. median postoperative score for arthroplasty = 83/100 (range 74–95) For arthrodesis = 82/100 (range 78–89) | Compared the AOFAS-HMI between different studies (either arthroplasty or arthrodesis rather than within studies. No RCT included in appraisal. High chance of publication bias Some types of implants not Included |
Baumhauer 2016 UK & Canada | 152 arthroplasty (mean age 57.4 ± 8.8yrs) and 50 arthrodesis (mean age 54.9 ± 10.5yrs) patients with advanced-stage hallux rigidus | Level I, prospective randomized study. | 1. VAS for pain @ 1 yr & 2 yrs (arthroplasty v arthrodesis) | 1. @ 1 yr FU 17.8 (±23) v 5.7(±8.5) p=0.0011 @2 yrs FU 14.5 (±22.1) v 5.9 (±12.1) p=0.002 | 23% loss of the arthrodesis patients who initially consented to randomization. |
2. FAAM ADL score @1 yr & 2 yrs (arthroplasty v arthrodesis) | 2. @ 1 yr FU 88.6 (±14.4) v 94.1 (±6.8) NSS. @2 yrs FU 90.4 (±15.0) v 94.6 (±7.4) NSS. | ||||
3. FAAM Sportscore @1 yr & 2 yrs (arthroplasty v arthrodesis) | 3. @ 1 yr FU 75.8 (±24.8) v 84.1 (±16.9) p = 0.043 @ 2 yrs FU 79.5 (±24.6) v 82.7 (±20.5) p = 0.461 |